May is Stroke Awareness Month: Environmental factors can increase your risks for strokes
Case Western Reserve University
Researchers at the Department of Biology, University of Copenhagen, have now contributed to solving this problem for a specific gene called GCK. The study has just been published in Genome Biology.
A new study by researchers at the Friedman School of Nutrition Science and Policy at Tufts University and others, shows how bringing together coalitions of individuals from government, public health, healthcare, public education, and other arenas to address a public health issue--in this case early childhood obesity--can result in better policies, systems, and environments for change.
Through data-analysis, researchers found that people taking long siestas had higher body mass indexes and were more likely to have metabolic syndrome than those who did not take siestas.
The BD Diabetes Center at Atlantic Health System’s Goryeb Children’s Hospital and diabetes research and advocacy organization JDRF, partnered to distribute a video series focusing on helping teens and young adults overcome the emotional challenges associated with newly diagnosed type 1 diabetes.
Research to Prevent Blindness (RPB) announces two new grants to support high-impact vision research. The new grants are the: RPB / Tom Wertheimer Career Development Award in Data Science and RPB / Mary Tyler Moore Vision Initiative Physician-Scientist Award.
UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
New research results suggest that the widely used diabetes drug metformin may be beneficial for recovering from short periods of severe food insecurity or anorexia.
The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, a bipartisan insulin affordability bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME). This legislation would cap out-of-pocket insulin costs for those with private insurance, ensure patients can share in insulin rebates and discounts, and promote competition in the insulin market.
Women with chronic hypertension and diabetes who were enrolled in an award-winning program for 12 months after childbirth were more likely to keep follow-up health care visits, which in turn led to improved care, according to initial findings of the program published in The Joint Commission Journal on Quality and Patient Safety.
Researchers from the University of Turku in Finland discovered that women who developed prediabetes after pregnancy had aberrations already in their early pregnancy blood serum metabolomic profile.
Scientists in Melbourne have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs.
In the journal Angewandte Chemie, a research team has now introduced a novel insulin formulation that can be switched on by glucose: Lipid nanoparticle carriers release more or less insulin depending on the blood sugar level.
Type 2 diabetes (T2D) is surging among U.S. children. The number of youths under age 20 living with the disease has nearly doubled between 2001 and 2017, and yet—aside from increases in childhood obesity—the reasons for this disturbing increase are not clear. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), has awarded the Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine a six-year, $4.1 million grant to identify the biological and social factors that cause children and adolescents to develop the condition.
Centers of Wellness for Urban Women Presents Free Webinar “How to beat diabetes with a plant-based diet and physical fitness” in conjunction with April Defeat Diabetes Month
La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator of the Year Award from the Network for Pancreatic Organ donors with Diabetes (nPOD). This prestigious award recognizes Quesada Masachs' groundbreaking research in type 1 diabetes.
A research model of dietary intake in 184 countries estimates poor diet contributed to over 14.1 million cases of type 2 diabetes in 2018, representing over 70% of new diagnoses globally.
A researcher from Wayne State University’s Department of Biological Sciences has received a five-year, $1.95 million grant from the National Institute of General Medical Sciences of the National Institutes of Health to identify mechanisms that regulate inositol synthesis in mammalian cells and determine the cellular consequences of inositol depletion.
Reducing caloric intake from added sugars is a Leading Health Indicator in Healthy People 2030, a national public health initiative led by the US Department of Health and Human Services that sets data-driven national objectives to improve health and wellbeing over the next decade.
Ochsner Health is one of 20 sites in the U.S. participating in the PROMISE II clinical trial, which was recently published in the New England Journal of Medicine.
A new Japanese study reveals significant birth cohort effects on the incidence trend of ESKD requiring RRT.
Below are some of the latest headlines in the new Avian Flu channel on Newswise.
A machine learning model can effectively predict a patient’s risk for a sleep disorder using demographic and lifestyle data, physical exam results and laboratory values, according to a new study published this week in the open-access journal PLOS ONE.
Researchers of the Genome Dynamics Project team at Tokyo Metropolitan Institute of Medical Science ·revealed new mechanism controlling cellular proliferation in response to serum, which triggers growth of resting cells.
An international study shows that it is likely that insulin can be stored at room temperature, and for considerably longer than drug companies have counted on to date. Access to this vital medicine can thereby be significantly improved for the world’s poorest inhabitants. Researchers at the University of Gothenburg are among the scientists presenting these results.
A new analysis led by Alex K. Gertner, MD, PhD, psychiatry resident at UNC Hospitals, has added further evidence that the new model is effective.
For more than 100 million Americans who are obese, bariatric surgery may reverse complications related to diabetes, including regenerating damaged nerves, a Michigan Medicine study shows. Researchers say the findings suggest that bariatric surgery likely enables the regeneration of the peripheral nerves and, therefore, may be an effective treatment for millions of individuals with obesity who are at risk of developing diabetes and peripheral neuropathy.
Analysing changes to DNA in the blood can improve the ability to predict a person’s risk of developing type 2 diabetes within a decade.
New research suggests a strategy to ward off age-related weight gain, which could prevent obesity and associated health disorders like Type 2 diabetes, heart disease and chronic inflammation.
A fasting diet which focuses on eating early in the day could be the key to reducing the risk of developing type 2 diabetes, following the largest study in the world to date.
Patients with obstructive sleep apnea (OSA) often show cognitive deficits, but these have traditionally been attributed to co-morbidities such as as systemic hypertension, cardiovascular and metabolic diseases, and type 2 diabetes.
Irvine, Calif., April 5, 2023 — Eating lots of fats increases the risk of metabolic disorders, but the mechanisms behind the problem have not been well understood. Now, University of California, Irvine biologists have made a key finding about how to ward off harmful effects caused by a high-fat diet. Their study appears in Nature Communications.
The University of Chicago Medicine Kovler Diabetes Center raised more than $35,000 at its annual Salon Kovler event, which supports the health system's critical diabetes care and research initiatives that are focused on reducing healthcare disparities. The March 9 fundraiser and educational program at Navy Pier brought together community stakeholders, corporate leaders, and UChicago Medicine faculty and staff for a conversation about diabetes disparities and how to overcome them.
Chronic kidney disease is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. A new risk model for cardiovascular disease, developed by Penn, was found to be more accurate than existing clinical models.
A roundup of the latest medical discoveries and faculty news happening at Cedars-Sinai in March 2023.
Researchers at Carnegie Mellon University are developing lipid nanoparticles that are designed to carry mRNA specifically to the pancreas. Their study in mice could pave the way for novel therapies for intractable pancreatic diseases, such as diabetes and cancer.
New initiative looks to improve health care access across our Borderplex by helping prevent diabetes and empowering screened residents with appropriate resources. The program has been in operation since February 2023.
Researchers at the University of Washington have developed GlucoScreen, a system that could enable people to self-screen for prediabetes.
A study, co-led by University Hospitals Harrington Heart & Vascular Institute, could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to amputation.
Housed at the University of Chicago Medicine, the Bridging the Gap: Reducing Disparities in Diabetes Care Initiative has published the results of their five-year project aimed at addressing disparities in diabetes care nationwide.
Imagine getting the benefits of gastric bypass surgery without going under the knife. A new class of potential treatments has done that in lab animals, reducing weight dramatically and lowering blood glucose without side effects, scientists report. They will present their results at ACS Spring 2023.
From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.
Weight loss was associated with decreased risk factors for cardiovascular disease and Type 2 diabetes for at least five years — even if some weight was regained, according to a review of research on behavioral weight loss programs.
Researchers have identified two distinct subtypes of insulin-producing beta cells, or ß cells, each with crucial characteristics that may be leveraged to better understand and treat Type 1 and Type 2 diabetes.